Cargando…
Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis
OBJECTIVE: Competition among trials for patient enrollment can impede recruitment. We hypothesized that this occurred early in the COVID-19 pandemic, when an unprecedented number of clinical trials were launched. We performed a simple and multivariable regression analysis evaluating the relationship...
Autores principales: | Hutchinson, Nora, Klas, Katarzyna, Carlisle, Benjamin G., Polak, Maciej, Kimmelman, Jonathan, Waligora, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742655/ https://www.ncbi.nlm.nih.gov/pubmed/36510308 http://dx.doi.org/10.1186/s13104-022-06263-1 |
Ejemplares similares
-
How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov
por: Hutchinson, Nora, et al.
Publicado: (2022) -
Clinical development success rates and social value of pediatric Phase 1 trials in oncology
por: Wasylewski, Mateusz T., et al.
Publicado: (2020) -
Ethical challenges of clinical trials with a repurposed drug in outbreaks
por: Klas, Katarzyna, et al.
Publicado: (2023) -
Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
por: Hutchinson, Nora, et al.
Publicado: (2021) -
Patient burden and clinical advances associated with postapproval monotherapy cancer drug trials: a retrospective cohort study
por: Carlisle, Benjamin Gregory, et al.
Publicado: (2020)